NCT05925647View on ClinicalTrials.gov

The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

March 9, 2023

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Messenchymal stem cell secretome

Mesenchymal stem cell secretome obtained from Kalbe Pharma Company

DRUG

Placebo

NaCl 0,9% infusion

Trial Locations (1)

Unknown

Moewardi General Hospital, Surakarta

All Listed Sponsors
lead

Universitas Sebelas Maret

OTHER